Although virtually an unknown condition in the mid-20th century, celiac disease has since
increased in both recognition and frequency. 1 The seroprevalence of celiac disease is …

Autoimmune enteropathy (AIE) is a rare condition characterized by intractable diarrhea and
immune-mediated injury of the intestinal mucosa. As the clinical and histopathologic …

Intestinal damage in malnutrition constitutes a threat to the survival of many thousands of
children globally. We studied children in Lusaka, Zambia, with severe acute malnutrition …

Background Multiple case reports suggest that olmesartan may be linked to sprue‐like
enteropathy; however, few epidemiological studies have examined this association and …

Olmesartan, a well-known and powerful antihypertensive drug, was first described to cause
enteropathy in 2012. A possible mechanism may be inhibition of the intestinal immune …

Sprue-like enteropathy associated with olmesartan, first identified by our group in 2012, 1 is
characterized by chronic diarrhea (often severe) and weight loss that is unresponsive to a …

Background Angiotensin receptor blocker‐associated enteropathy (ARB‐e) is an
increasingly recognised clinical entity with symptoms and histological findings identical to …

Olmesartan, a recently introduced angiotensin II receptor blocker for hypertension, has been
reported to cause drug-induced small bowel enteropathy. The diagnosis of olmesartan …

Background Although enteropathy due to angiotensin II receptor blockers (ARBs) has been
known for over 10 years, clinicians' awareness of this condition is still low. Aims To …

Over the past 5 years several case reports and cohort studies have been published that
describe a sprue-like enteropathy (SLE) with abdominal pain, chronic diarrhea and weight …